Cargando…

Osteoanabolic Agents for Osteoporosis

Medications for osteoporosis are classified as either antiresorptive or anabolic. Whereas antiresorptive agents prevent bone resorption, anabolic agents promote new bone formation. Anabolics should be considered in individuals with severe osteoporosis, failure of alternative osteoporosis agents, int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haas, Andrea V, LeBoff, Meryl S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Mini-Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065487/ https://www.ncbi.nlm.nih.gov/pubmed/30087947 http://dx.doi.org/10.1210/js.2018-00118

Ejemplares similares

Osteoanabolics
por: Gupta, Vishal, et al.
Publicado: (2012)

Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells
por: Alloisio, Giulia, et al.
Publicado: (2021)

Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health
por: Kostenuik, Paul J., et al.
Publicado: (2023)

Relevance of Wnt signaling for osteoanabolic therapy
por: Yorgan, Timur A, et al.
Publicado: (2014)

Clinician’s Guide to Prevention and Treatment of Osteoporosis
por: Cosman, F., et al.
Publicado: (2014)

Chondroitin sulfate-E mediates estrogen-induced osteoanabolism
por: Koike, Toshiyasu, et al.
Publicado: (2015)

Erratum to: Clinician’s guide to prevention and treatment of osteoporosis
por: Cosman, F., et al.
Publicado: (2015)

The clinician’s guide to prevention and treatment of osteoporosis
por: LeBoff, M. S., et al.
Publicado: (2022)

Correction to: The clinician’s guide to prevention and treatment of osteoporosis
por: LeBoff, M. S., et al.
Publicado: (2022)

Periostin in Osteoporosis and Cardiovascular Disease
por: Pickering, Marie-Eva, et al.
Publicado: (2023)

Brigham Fracture Intervention Team Initiatives for Hospital Patients with Hip Fractures: A Paradigm Shift
por: Glowacki, Julie, et al.
Publicado: (2010)

Effect of vitamin D on serum markers of bone turnover in SLE in a randomised controlled trial
por: Tedeschi, Sara K., et al.
Publicado: (2019)

Animal versus plant protein and adult bone health: A systematic review and meta-analysis from the National Osteoporosis Foundation
por: Shams-White, Marissa M., et al.
Publicado: (2018)

New Horizons: Artificial Intelligence Tools for Managing Osteoporosis
por: Dimai, Hans Peter
Publicado: (2022)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
por: Watts, N.B., et al.
Publicado: (2020)

Osteoporosis: the current status of mesenchymal stem cell-based therapy
por: Phetfong, Jitrada, et al.
Publicado: (2016)

Effects of osteoanabolic exercises on bone mineral density of osteoporotic females: A randomized controlled trial
por: Khan, Amna Aamir, et al.
Publicado: (2019)

Effect of Dietary Composition of Weight Loss Diets on High Sensitivity C-Reactive Protein: The Randomized POUNDS LOST Trial
por: Nicklas, Jacinda M., et al.
Publicado: (2013)

Concerted Action of Androgens and Mechanical Strain Shifts Bone Metabolism from High Turnover into an Osteoanabolic Mode
por: Liegibel, Ute M., et al.
Publicado: (2002)

Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
por: Xie, Yangli, et al.
Publicado: (2016)

Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats
por: Arlt, Heike, et al.
Publicado: (2020)

The role of genetic and epigenetic factors in determining the risk of spinal fragility fractures: new insights in the management of spinal osteoporosis
por: Himič, Vratko, et al.
Publicado: (2023)

640. Prospective Association of Serum Vitamin D Level with Sepsis-Mortality in Postmenopausal Women: Results From the Women’s Health Initiative
por: Pinargote, Paulette, et al.
Publicado: (2018)

Short-term effects of teriparatide versus placebo on bone biomarkers, structure, and fracture healing in women with lower-extremity stress fractures: A pilot study
por: Almirol, Ellen A., et al.
Publicado: (2016)

Demethylbelamcandaquinone B (Dmcq B) Is the Active Compound of Marantodes pumilum var. alata (Blume) Kuntze with Osteoanabolic Activities
por: Ahmad Hairi, Haryati, et al.
Publicado: (2018)

Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide
por: Sahbani, Karim, et al.
Publicado: (2019)

Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
por: Weaver, C. M., et al.
Publicado: (2015)

Pharmacologic agents for smoking cessation: A clinical review
por: Patel, Dilip R, et al.
Publicado: (2010)

Drug repurposing strategies in the development of potential antifungal agents
por: Zhang, Qian, et al.
Publicado: (2021)

Slime molds as a valuable source of antimicrobial agents
por: Tafakori, Vida
Publicado: (2021)

Flaviviruses as agents of childhood central nervous system infections in Brazil
por: Marinho, P.E.S., et al.
Publicado: (2019)

Cyclophilin A: a key player for etiological agent infection
por: Liao, Yating, et al.
Publicado: (2021)

Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
por: Chai, Jong-Yil, et al.
Publicado: (2021)

Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation
por: Martinez de Pinillos Bayona, Alejandra, et al.
Publicado: (2016)

Multi-drug resistant ESKAPE pathogens and the uses of plants as their antimicrobial agents
por: Idris, Farhana Nazira, et al.
Publicado: (2023)

Hepatobiliary-specific magnetic resonance contrast agents: role in biliary trauma
por: Di Serafino, Marco, et al.
Publicado: (2023)

VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population
por: LeBoff, Meryl S, et al.
Publicado: (2020)

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
por: Lorentzon, Mattias, et al.
Publicado: (2022)

Potential therapeutic agents against COVID-19: What we know so far
por: Lu, Chih-Chia, et al.
Publicado: (2020)

Modeling the dynamic kinetics of microbial disinfection with dissipating chemical agents—a theoretical investigation
por: Peleg, Micha
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6312jp4opdloctke8buvrd4jv0